David Karli Launches New Treatment for Patients with severe Arthritic Conditions

Colorado-based doctor, David Karli, has announced the launch of a new bone marrow-derived stem cell injection program for patients with arthritic conditions and both acute and chronic soft tissue disorders of muscle, tendon and ligament.

The Elizabethtown College graduate is a former Chief Resident of the Harvard Medical School Department of Physical Medicine & Rehabilitation and runs a fitness programme for enterpreneurs with hectic schedules.

Dr Karli’s avid interest in regenerative medicine and the development of non-surgical interventions for a variety of conditions has led to the development of Platelet Rich Plasma (PRP, Platelet Gel) and Bone Marrow Stem Cell injection therapy programs for patients with acute and chronic musculoskeletal injuries.

His work with The Steadman Clinic has lead to pioneering work in developing safe and effective use of biologics in orthopaedic medicine for both surgical and non-surgical applications.

A Diplomate of the American Board of Physical Medicine and Rehabilitation, Dr. Karli also maintains active membership in multiple professional societies. He was a recent co-investigator in the first Level I randomized, double-blind, placebo-controlled clinical trial researching the efficacy of PRP in chronic tennis elbow, a landmark study slated for publication in the American Journal of Sports Medicine.